Evidence map›Paper›PMID 32276977›Full record

ArticleApplied and environmental microbiology2020

Exploiting the Diversity of Saccharomycotina Yeasts To Engineer Biotin-Independent Growth of Saccharomyces cerevisiae.

Anna K Wronska, Meinske P Haak, Ellen Geraats, Eva Bruins Slot, Marcel van den Broek, Jack T Pronk, Jean-Marc Daran

Open access · hybridAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. A versatile genetic toolkit for engineeringFrontiers in bioengineering and biotechnology · 2025
    Article
  3. Article
  4. Isolation and evaluation ofFrontiers in microbiology · 2024
    Article
  5. Article
  6. Elimination of aromatic fusel alcohols as by-products ofMetabolic engineering communications · 2021
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anna K WronskaDepartment of Biotechnology, Delft University of Technology, Delft, The Netherlands.ORCID 0000-0002-6103-3039
Meinske P HaakDepartment of Biotechnology, Delft University of Technology, Delft, The Netherlands.
Ellen GeraatsDepartment of Biotechnology, Delft University of Technology, Delft, The Netherlands.
Eva Bruins SlotDepartment of Biotechnology, Delft University of Technology, Delft, The Netherlands.
Marcel van den BroekDepartment of Biotechnology, Delft University of Technology, Delft, The Netherlands.
Jack T PronkDepartment of Biotechnology, Delft University of Technology, Delft, The Netherlands.ORCID 0000-0002-5617-4611
Jean-Marc DaranDepartment of Biotechnology, Delft University of Technology, Delft, The Netherlands J.G.Daran@tudelft.nl.ORCID 0000-0003-3136-8193
Delft University of Technology · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biotin, an important cofactor for carboxylases, is essential for all kingdoms of life. Since native biotin synthesis does not always suffice for fast growth and product formation, microbial cultivation in research and industry often requires supplementation of biotin.

Indexed as

AscomycotaBiotinMetabolic EngineeringMicroorganisms, Genetically-ModifiedSaccharomyces cerevisiaeYeastsBiotinBIO1biotinCyberlindnera fabianiide novo synthesisfungal biotin synthesismetabolic engineeringoxygen requirementoxygen-requiring enzymeprototrophySaccharomyces cerevisiaeSaccharomycotinavitamin B7

Identifiers

PMID32276977
PMCPMC7267198
OpenAlexW3015270074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.